Population pharmacokinetics and dose optimisation of colecalciferol in paediatric patients with chronic kidney disease-Reference-Cited by-同舟云学术

Population pharmacokinetics and dose optimisation of colecalciferol in paediatric patients with chronic kidney disease

Published:2021-09-30 Issue: Volume: Page:
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Wan Mandy¹²^ORCID,Green Bruce³^ORCID,Iyengar Arpana Aprameya⁴^ORCID,Kamath Nivedita⁴,Reddy Hamsa V.⁴,Sharma Jyoti⁵,Singhal Jyoti⁵,Uthup Susan⁶,Ekambaram Sudha⁷,Selvam Sumithra⁴,Rait Greta⁸^ORCID,Shroff Rukshana⁹^ORCID,Patel Jignesh P.²¹⁰^ORCID

Affiliation:

1. Pharmacy Department Guy's and St Thomas' NHS Foundation Trust, Evelina London Children's Hospital London UK

2. Institute of Pharmaceutical Science King's College London London UK

3. Model Answers R&D Brisbane Australia

4. Department of Paediatric Nephrology St John's Medical College Hospital Bengaluru India

5. Paediatric renal service unit, King Edward Memorial Hospital Pune India

6. Department of Paediatric Nephrology Government Medical College Trivandrum India

7. Department of Paediatric Mehta Multispecialty Hospital Chennai India

8. Research Department of Primary Care and Population Health University of College London London UK

9. Renal Unit UCL Great Ormond Street Hospital Institute of Child Health London UK

10. Department of Haematological Medicine King's College Hospital Foundation NHS Trust London UK

Funder

National Institute for Health Research

Sir Ratan Tata Trust and Navajbai Ratan Tata Trust

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15064

Reference45 articles.

1. Vitamin D deficiency in children with chronic kidney disease: uncovering an epidemic;Ali FN;Pediatrics,2009

2. Vitamin D insufficiency, hemoglobin, and anemia in children with chronic kidney disease;Altemose KE;Pediatr Nephrol,2018

3. Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease Stages 2–5 and on dialysis;Shroff R;Nephrol Dial Transplant,2017

4. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease‐Mineral and Bone Disorder (CKD‐MBD);Kidney Disease: Improving Global Outcomes (KDIGO) CKD‐MBD Update Work Group;Kidney Int Suppl,2017

5. Scientific Advisory Committee on Nutrition.SACN vitamin D and health report.https://www.gov.uk/government/publications/sacn-vitamin-d-and-health-reportAccessed June 23 2017.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and management of mineral and bone disorders in infants with CKD: clinical practice points from the ESPN CKD-MBD and Dialysis working groups and the Pediatric Renal Nutrition Taskforce;Pediatric Nephrology;2023-02-14

2. The clinical relevance of native vitamin D in pediatric kidney disease;Pediatric Nephrology;2022-08-05

3. Hypervitaminosis D and nephrocalcinosis: too much of a good thing?;Pediatric Nephrology;2022-03-29